Global Clinical Trial Imaging Services Market analysis segmented by Product and Services (Trial Design Consulting Services, Read Analysis Services, Operational Imaging Services, Imaging Software). By Modality (Magnetic Resonance Imaging, Computed Tomography, Ultrasound, Positron Emission Tomography, X-Ray, Echocardiography, Other Modalities). By End Users (Pharmaceutical Companies, Medical Device Manufacturers, Academic and Government Research Institutes, Other End-Users). Regional Forecasting t
-
Product Code:
RP-ID-10346922 -
Published Date:
25 Mar 2021 -
Region:
Global
-
Pages:
200 -
Category:
Healthcare & Pharmaceuticals -
Publisher:
Pub-ID-14
Impact Analysis on the Growth of Market
Activating Probable Propositions Amidst COVID-19 Crisis
With things going haywire, we analyze key points to make sure that the businesses around the globe are completely prepared to tackle potential implications caused by COVID-19. Be it protecting employees, customers or the overall business operations, we ensure that the employers take the right decisions, make strategic investments and maintain a healthy work culture along with taking probable measures to minimize the financial loss. Know More
Market Overview
Global Clinical Trial Imaging Services Market was valued at 1.3 Billion US Dollar in 2019 and expected to grow with a CAGR 5.6%. Clinical Trial imaging services are used in clinical and non-clinical trial since years. This is a set of services offered to companies such as pharmaceutical, medical device and biotechnology by contract research organization. In which many services are offered in open market such as project and data management services, image analysis, quality control and other. For instance, services such as project management has team of experts which manage workflow of a clinical trial. Additionally, these services are offered for different types of therapeutic expertise such as neurology, oncology, endocrinology, and others. Rise in adoption of imaging in clinical trials and advancements in the field of medical imaging technology are key drives of the global Clinical Trial Imaging Market. For instance, In 2020, as per Radiology Society of North America, in new development of Digital breast tomosynthesis it is found that Digital Breast Tomosynthesis Improves Invasive Cancer Detection. Analysis showed that screening with DBT improves sensitivity specificity for breast cancer and identified more invasive cancers.Despite that, challenges related to integration of imaging in clinical trials is restrain the market growth of Clinical Trial Imaging Services during forecasting years 2020-2027.
The regional analysis of the Clinical Trial Imaging Services Market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America, and Rest of the World. In which, North America leading the Global market of Clinical Trial Imaging Services owing to surge in use of imaging as an endpoint in clinical trials. However, APAC region holds largest market share of Clinical trial Imaging Services due to rising awareness related Imaging Clinical trial which grow the market during forecasting period 2020-2027.
Key Players in Global Clinical Trial Imaging Services Market
Biotelemetry Inc.
Biomedical Systems Corporation
Bio Clinica Inc.
Cardiovascular Imaging Technologies LLC
Icon PLC
Intrinsic Imaging LLC
Ixico PLC
Parexel International Corporation
Radiant Sage LLC
Worldcare Clinical LLC
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Software and Services:
Clinical Trial Design & Consultation Services
Reading & Analytical Services
Operational Imaging Services
Project & Data Management Services
Others
By Modality:
Magnetic Resonance Imaging
Computed Tomography
Ultrasound
Positron Emission Tomography
X-Ray
Echocardiography
Other Modalities
By End Users:
Pharmaceutical Companies
Medical Device Manufacturers
Academic and Government Research Institutes
Other End-Users
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
Asia Pacific
China
India
Japan
Australia
Latin America
Brazil
Mexico
Rest of LA
Rest of the World
Furthermore, years considered for the study are as follows:
Historical year – 2017, 2018
Base year – 2019
Forecast period – 2020 to 2027
Target Audience of Global Clinical Trial Imaging Services Market in Market Study:
Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors
Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2018-2027 (USD Billion)
1.2.1. Global Clinical Trial Imaging Services Market, by Product and Services, 2018-2027 (USD Billion)
1.2.2. Global Clinical Trial Imaging Services Market, by Modality, 2018-2027 (USD Billion)
1.2.3. Global Clinical Trial Imaging Services Market, by End Users, 2018-2027 (USD Billion)
1.2.4. Global Clinical Trial Imaging Services Market, By Region, 2018-2027 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Clinical Trial Imaging Services Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Clinical Trial Imaging Services Market Dynamics
3.1. Global Clinical Trial Imaging Services Market Impact Analysis (2018-2027)
3.1.1. Market Drivers
3.1.2. Market Challenges
3.1.3. Market Opportunities
Chapter 4. Global Clinical Trial Imaging Services Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Force Model (2018-2027)
4.2. PEST Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.3. Investment Adoption Model
4.4. Analyst Recommendation & Conclusion
4.1. Global Clinical Trial Imaging Services Market, by Product and Services
4.2. Market Snapshot
4.3. Global Clinical Trial Imaging Services Market by Source, Performance - Potential Analysis
4.4. Global Clinical Trial Imaging Services Market Estimates & Forecasts bySoftware and Services 2018-2027 (USD Billion)
4.5. Global Clinical Trial Imaging Services Market, Sub Segment Analysis
5.4.1 clinical Trial Design & Consultation Services
5.4.2 Reading & Analytical Services
5.4.3 Operational Imaging Services
5.4.4 Project & Data Management Services
5.4.5 Others
Chapter 5. Global Clinical Trial Imaging Services Market, by Modality
5.1. Market Snapshot
5.2. Global Clinical Trial Imaging Services Market by Source, Performance - Potential Analysis
5.3. Global Clinical Trial Imaging Services Market Estimates & Forecasts by Modality, 2018-2027 (USD Billion)
5.4. Global Clinical Trial Imaging Services Market, Sub Segment Analysis
5.4.1. Magnetic Resonance Imaging
5.4.2. Computed Tomography
5.4.3. Ultrasound
5.4.4. Positron Emission Tomography
5.4.5. X-Ray
5.4.6. Echocardiography
5.4.7. Other Modalities
Chapter 6. Global Clinical Trial Imaging Services Market, by End Users
6.1. Market Snapshot
6.2. Global Clinical Trial Imaging Services Market by Source, Performance - Potential Analysis
6.3. Global Clinical Trial Imaging Services Market Estimates & Forecasts by End users, 2018-2027 (USD Billion)
6.4. Global Clinical Trial Imaging Services Market, Sub Segment Analysis
6.4.1. Pharmaceutical Companies
6.4.2. Medical Device Manufacturers
6.4.3. Academic and Government Research Institutes
6.4.4. Other End-Users
Chapter 7. Global Clinical Trial Imaging Services Market, Regional Analysis
7.1. Global Clinical Trial Imaging Services Market, Regional Market Snapshot
7.2. North America Global Clinical Trial Imaging Services Market
7.2.1. U.S. Global Clinical Trial Imaging Services Market
7.2.1.1. Product and Services breakdown estimates & forecasts, 2018-2027
7.2.1.2. Modality breakdown estimates & forecasts, 2018-2027
7.2.1.3. End Users breakdown estimates & forecasts, 2018-2027
7.2.2. Canada Global Clinical Trial Imaging Services Market
7.3. Europe Global Clinical Trial Imaging Services Market Snapshot
7.3.1. U.K. Global Clinical Trial Imaging Services Market
7.3.2. Germany Global Clinical Trial Imaging Services Market
7.3.3. France Global Clinical Trial Imaging Services Market
7.3.4. Spain Global Clinical Trial Imaging Services Market
7.3.5. Italy Global Clinical Trial Imaging Services Market
7.3.6. Rest of Europe Global Clinical Trial Imaging Services Market
7.4. Asia-Pacific Global Clinical Trial Imaging Services Market Snapshot
7.4.1. China Global Clinical Trial Imaging Services Market
7.4.2. India Global Clinical Trial Imaging Services Market
7.4.3. Japan Global Clinical Trial Imaging Services Market
7.4.4. Australia Global Clinical Trial Imaging Services Market
7.5. Latin America Global Clinical Trial Imaging Services Market Snapshot
7.6. Rest of The World Global Clinical Trial Imaging Services Market
Chapter 8. Competitive Intelligence
8.1. Top Market Strategies
8.2. Company Profile
8.2.1. Biotelemetry Inc.
8.2.1.1. Key Information
8.2.1.2. Overview
8.2.1.3. Financial (Subject to Data Availability)
8.2.1.4. Product Summary
8.2.1.5. Recent Developments
8.2.2. Biomedical Systems Corporation
8.2.3. Bioclinica Inc.
8.2.4. Cardiovascular Imaging Technologies LLC
8.2.5. Icon PLC
8.2.6. Intrinsic Imaging LLC
8.2.7. Ixico PLC
8.2.8. Parexel International Corporation
8.2.9. Radiant Sage LLC
8.2.10. Worldcare Clinical LLC
Chapter 9. Research Process
9.1. Research Process
9.1.1. Data Mining
9.1.2. Analysis
9.1.3. Market Estimation
9.1.4. Validation
9.1.5. Publishing
9.2. Research Attributes
9.3. Research Assumption
Please enter your personal details below
Biotelemetry Inc.
Biomedical Systems Corporation
Bio Clinica Inc.
Cardiovascular Imaging Technologies LLC
Icon PLC
Intrinsic Imaging LLC
Ixico PLC
Parexel International Corporation
Radiant Sage LLC
Worldcare Clinical LLC
